Mednax Inc (MD)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -48,359 | 85,141 | 158,205 | -779,760 | -1,481,130 |
| Revenue | US$ in thousands | 1,952,560 | 1,875,310 | 1,820,660 | 1,623,470 | 3,394,160 |
| Pretax margin | -2.48% | 4.54% | 8.69% | -48.03% | -43.64% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-48,359K ÷ $1,952,560K
= -2.48%
Pretax margin is a key financial ratio that indicates the percentage of a company's revenue that turns into pre-tax profit. Pediatrix Medical Group Inc's pretax margin has fluctuated over the past five years. In 2023, the pretax margin was negative at -2.42%, indicating that the company's expenses exceeded its revenue before taxes. This significant drop from the previous year's 4.13% pretax margin suggests a decline in profitability and efficiency in managing costs.
In 2022, the pretax margin was 4.13%, showing that the company generated a pre-tax profit of 4.13% of its total revenue. This was a positive sign of profitability and improved performance compared to the previous years. The 7.08% pretax margin in 2021 was even higher, indicating better control over expenses and improved operational efficiency.
The pretax margin of 0.41% in 2020 suggests a narrow gap between revenue and pre-tax profit, which could be a concern for the company's ability to generate profits efficiently. In contrast, the pretax margin of -35.35% in 2019 reflects a substantial loss, impacting the company's overall financial health negatively.
Overall, the trend in Pediatrix Medical Group Inc's pretax margin shows variability in profitability over the years. Analyzing the factors influencing these fluctuations can provide insights into the company's financial performance and help in making informed decisions for future growth and sustainability.
Peer comparison
Dec 31, 2023